Nestle Sa ADR (NSRGY)

$101.18 -0.49 (-0.48%)
Market Cap 260.69B
Revenue (ttm) 104.18B
Net Income (ttm) 12.36B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 18.47
Profit Margin 11.87%
Debt to Equity Ratio 2.26
Volume 292,600
Avg Vol 584,552
Day's Range N/A - N/A
Shares Out 2.58B
Stochastic %K 76%
Beta 0.48
Analysts Sell
Price Target $109.33

Company Profile

Nestlé S.A., together with its subsidiaries, operates as a food and beverage company. It operates through Zone North America; Zone Europe; Zone Asia, Oceania and Africa; Zone Latin America; Zone Greater China; Nestlé Health Science; and Nespresso segments. The company offers water under the Acqua Panna, Nestlé Pure Life, Perrier, S.Pellegrino, Sanpellegrino, and other local brands; and chocolate and confectionery products under the Aero, Baci Perugina, KitKat, Milkybar, Smarties, and other local...

Industry: Packaged Foods
Sector: Consumer Defensive
Phone: 41 21 924 1111
Address:
Avenue Nestlé 55, Vevey, Switzerland
Okadarlan
Okadarlan Nov. 9 at 10:01 AM
$NSRGY hope u all followed this one.
0 · Reply
bulld0zer40k
bulld0zer40k Nov. 9 at 6:45 AM
$CELH I have the same experience holding $AIMT years ago before $NSRGY bought them. The stock price was significantly depressed by hedge funds to help with the acquisition. I believe PepsiCo is doing the same thing to save their growth problem. They are trying to convince the shareholders that Celsius is failing in execution and it’s wise to sell for <$100 BO.
0 · Reply
SenefAS
SenefAS Nov. 4 at 12:00 PM
Seres Therapeutics advanced earnings on the 5 November… Jurisdiction vs Vedanta are on the 6 November with Nestle hand in hand represented by the same lawyers… What’s the next move ? Buyout or partnership on the 7 November ? $MCRB $NSRGY $VEDL $XBI #biotech
2 · Reply
SenefAS
SenefAS Nov. 4 at 11:50 AM
$MCRB Nice find @Thepark88 This is the reason why the VOWST sales are confidential… Same lawyers representing Seres & Nestle hand in hand $NSRGY When buyout ?
0 · Reply
SenefAS
SenefAS Oct. 30 at 2:41 PM
$MCRB You're not going to advance the earnings for the business update if you don't have any solutions... In my opinion, the next few days are crucial. $NSRGY
0 · Reply
BigBullyHauling
BigBullyHauling Oct. 29 at 5:29 PM
$BYND it was pre pandemic and before BYND flew to its crazy price but $NSRGY had target a partnership or MA. Now at today’s price and debt consolidation is the target back in sights? 🧐
0 · Reply
abubnic
abubnic Oct. 28 at 6:12 PM
$HSY $NSRGY $MDLZ ​October 28th is National Chocolate Day. You know what to do!
0 · Reply
Hastamatr
Hastamatr Oct. 22 at 3:16 AM
$OTLY And connecting the dots , with my previous post about Goudet. JDE Peets ($JDEPY) merging with Keurig ($KDP) and beverages will be spinned off. From JAB website : “JAB works with three globally recognized Senior Advisors who provide advice on investments and various governance and strategy matters: Bertrand Badré, Olivier Goudet, and Antonio Weiss.“ Oatly investment (10% of the company) of Goudet through Platin SARL must be personal but JAB-aligned signal of strategic interest in especially within the coffee ecosystem that JAB is now re-consolidating via the Keurig / JDE Peet’s combination… So it will not be Nestle($NSRGY ) that I was always thinking about… It will be one of the JAB future companies to take it over in 2027/2028 after merger&spin off finalizes. And first stone laid… Don’t get surprised if he increases his position gradually… Wow, now all makes much better sense … Prepare for the ride guys…🤩
2 · Reply
MisterSplashyPants
MisterSplashyPants Oct. 16 at 9:33 PM
$NSRGY Analysts ratings: 11 Buys, 12 Holds, and 1 Sell with an average 12-month PT of 85 CHF (Swiss Franc)
0 · Reply
Okadarlan
Okadarlan Oct. 16 at 3:50 PM
$NSRGY lets gooo
0 · Reply
Latest News on NSRGY
No data available.
Okadarlan
Okadarlan Nov. 9 at 10:01 AM
$NSRGY hope u all followed this one.
0 · Reply
bulld0zer40k
bulld0zer40k Nov. 9 at 6:45 AM
$CELH I have the same experience holding $AIMT years ago before $NSRGY bought them. The stock price was significantly depressed by hedge funds to help with the acquisition. I believe PepsiCo is doing the same thing to save their growth problem. They are trying to convince the shareholders that Celsius is failing in execution and it’s wise to sell for <$100 BO.
0 · Reply
SenefAS
SenefAS Nov. 4 at 12:00 PM
Seres Therapeutics advanced earnings on the 5 November… Jurisdiction vs Vedanta are on the 6 November with Nestle hand in hand represented by the same lawyers… What’s the next move ? Buyout or partnership on the 7 November ? $MCRB $NSRGY $VEDL $XBI #biotech
2 · Reply
SenefAS
SenefAS Nov. 4 at 11:50 AM
$MCRB Nice find @Thepark88 This is the reason why the VOWST sales are confidential… Same lawyers representing Seres & Nestle hand in hand $NSRGY When buyout ?
0 · Reply
SenefAS
SenefAS Oct. 30 at 2:41 PM
$MCRB You're not going to advance the earnings for the business update if you don't have any solutions... In my opinion, the next few days are crucial. $NSRGY
0 · Reply
BigBullyHauling
BigBullyHauling Oct. 29 at 5:29 PM
$BYND it was pre pandemic and before BYND flew to its crazy price but $NSRGY had target a partnership or MA. Now at today’s price and debt consolidation is the target back in sights? 🧐
0 · Reply
abubnic
abubnic Oct. 28 at 6:12 PM
$HSY $NSRGY $MDLZ ​October 28th is National Chocolate Day. You know what to do!
0 · Reply
Hastamatr
Hastamatr Oct. 22 at 3:16 AM
$OTLY And connecting the dots , with my previous post about Goudet. JDE Peets ($JDEPY) merging with Keurig ($KDP) and beverages will be spinned off. From JAB website : “JAB works with three globally recognized Senior Advisors who provide advice on investments and various governance and strategy matters: Bertrand Badré, Olivier Goudet, and Antonio Weiss.“ Oatly investment (10% of the company) of Goudet through Platin SARL must be personal but JAB-aligned signal of strategic interest in especially within the coffee ecosystem that JAB is now re-consolidating via the Keurig / JDE Peet’s combination… So it will not be Nestle($NSRGY ) that I was always thinking about… It will be one of the JAB future companies to take it over in 2027/2028 after merger&spin off finalizes. And first stone laid… Don’t get surprised if he increases his position gradually… Wow, now all makes much better sense … Prepare for the ride guys…🤩
2 · Reply
MisterSplashyPants
MisterSplashyPants Oct. 16 at 9:33 PM
$NSRGY Analysts ratings: 11 Buys, 12 Holds, and 1 Sell with an average 12-month PT of 85 CHF (Swiss Franc)
0 · Reply
Okadarlan
Okadarlan Oct. 16 at 3:50 PM
$NSRGY lets gooo
0 · Reply
StocktwitsNews
StocktwitsNews Oct. 16 at 2:23 PM
Nestle’s US-listed Shares Rally On Plans To Reduce 16,000 Global Jobs Over Two Years $NSRGY https://stocktwits.com/news/equity/markets/nestles-us-listed-shares-rally-on-plans-to-reduce-16-000-global-jobs/ch6p3LSR3np
0 · Reply
inspector_gadget86
inspector_gadget86 Oct. 16 at 8:07 AM
$NSRGY In a bid to improve operational efficiency, the firm said it will cut 12,000 white-collar jobs and a further 4,000 roles will be reduced over the next two years.
0 · Reply
StocktwitsNews
StocktwitsNews Oct. 16 at 7:10 AM
Nestle To Cut Nearly 6% Roles To Save Costs: Retail Mood Bearish $NSRGY $XLP https://stocktwits.com/news/equity/markets/nestle-to-cut-nearly-6-roles-to-save-costs-retail-mood-bearish/ch6YHwlR3Vp
0 · Reply
Numbersandfacts
Numbersandfacts Sep. 29 at 3:39 PM
$MCRB Danone, one of Nestle $NSRGY rivals and competitors, has acquired the akkermansia company. They understand the microbiome is the future of food, medicines and supplements. If Nestle doesn't want Seres its patents and pipeline, I say the admin should reach out to Danone!
0 · Reply
SenefAS
SenefAS Sep. 24 at 11:31 AM
Canaccord raised the price target on Seres Therapeutics to $22 from $14 and keeps a Buy rating on the shares. The firm noted the FDA provided feedback on Seres’ proposed Phase 2 SER-155 study in bloodstream infections, which could aid in partnership discussions $MCRB $XBI $NSRGY
0 · Reply
Numbersandfacts
Numbersandfacts Sep. 18 at 3:20 PM
$MCRB Danone has bought the Akkermansia company. $NSRGY your move!
0 · Reply
StreetwiseReports
StreetwiseReports Sep. 16 at 8:34 PM
Change of CEO at Nestle With Stock Undervalued https://ow.ly/1JPt50WXNCt Global Analyst Adrian Day shares a brief update on developments at three companies on his list. $NESN $NSRGY $OGN.V $OGNNF $PAAS
0 · Reply
Thepark88
Thepark88 Sep. 16 at 11:31 AM
$LLY $MCRB $NSRGY $SGTX more similarities, same as poseida, sit tight
1 · Reply
SenefAS
SenefAS Sep. 16 at 9:59 AM
Did you see similarities ? 🚨 Before the buyout of Sigilon $SGTX a company owned by Flagship the same company behind Seres $MCRB There was a corporate split and the company was bought out a month later... $NSRGY $NESN.SW $LLY
0 · Reply
SenefAS
SenefAS Sep. 15 at 8:38 AM
$IBB $MCRB $NSRGY $XBI Soon the big announcement ? 📣
0 · Reply
SenefAS
SenefAS Sep. 13 at 4:21 AM
📊 What the chart shows: •Strong rally from ~$6.20 in early April to ~$17.40 by early September (+181%). 📊 Key insights from the chart: $MCRB : ◦April 2025: ~$6.20 → Early Sept 2025: ~$17.40 (+181%) ◦Spiked above $22 intraday after the Sept 5 Nestlé $41/share bid the Sept 5 Nestlé $41/share bid before settling lower. $NSRGY #biotech $XBI $IBB Outperformed the biotech sector dramatically. Trend phases: •Light green zone = sustained uptrend •Light gray zone = consolidation •Salmon zone = September spike on Nestlé news And you still not believe in the BO 🙃
0 · Reply
SenefAS
SenefAS Sep. 10 at 9:02 PM
Did you have see that all the game player in the food industry buy a microbiome company the last in date it’s Danone : https://www.danone.com/newsroom/press-releases/acquisition-of-the-akkermansia-company.html $MCRB $DANOY $NSRGY $UL
2 · Reply